Anti-CLEC2 [AYP2]

Datasheet

References (2)

Inventor Info

Info

Catalogue Number	151914
Applications	WB
Antigen/Gene or Protein Targets	C-type lectin-like receptor 2, CLEC1b
Reactivity	Human papilloma virus
Relevance	Patients with rheumatoid arthritis, an inflammatory disease associated with increased microparticle production, have raised plasma levels of microparticles that expressed CLEC-2 but not GPVI. CLEC-2 can be used to monitor platelet-derived microparticles. The observation that microparticles derived from activated platelets retain CLEC-2 but lose GPVI highlights the potential use of measurement of surface expression of platelet receptors to screen for platelet activation in a wide variety of cardiovascular and inflammatory diseases.
Host	Mouse
Immunogen	A recombinant extracellular fragment of human CLEC-2 (aa 68-229), which is the extracellular domain of the protein.
Positive Control	Platelets
Subclass	IgG1
Molecular Weight (kDa)	26
Myeloma Used	Sp2/0-Ag14
Recommended Growing Conditions	Hybridomas were cultured at 37º C and 96% relative humidity in air containing 6% CO2. Cells were grown in complete DMEM + Pen/strep + FCS was used at 10%. Cell density: Cells should be kept between 1-2x105 cells/ml and 5x105 cells/ml.
Notes	Molecular Weight- Western blotting: 32 and 40 kDa doublet from lysates as CLEC-2 is glycosylated.
Research Area	Cardiovascular, Immunology

There are 2 reference entries for this reagent.

View All References

Gitz et al. 2014. Blood. 124(14):2262-70. PMID: 25150298.

View

CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

Europe PMC ID: 25150298

View

Add a reference

Gitz et al. 2014. Blood. 124(14):2262-70. PMID: 25150298.

View

CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

View

Add a reference

No inventors are currently linked to this reagent.

Add an inventor

	University Of Birmingham
	170 reagents listed on Ximbio

This reagent can be obtained from the following supplier. Click through to their website for more details.